Table 2.

Genotype, allele, and allelic combination frequencies of the rs3790567 IL12RB and rs1343151 IL23R gene polymorphisms in patients with biopsy-proven GCA and healthy controls.

GCAControlspOR (95% CI)
rs3790567 IL12RBn = 352 (%)n = 574 (%)
  GG166 (47.2)319 (55.6)1, Reference
  GA160 (45.4)215 (37.5)0.0111.43 (1.07–1.91)
  AA26 (7.4)40 (6.9)0.411.25 ((0.71–2.18)
  GA+AA186 (52.8)255 (44.4)0.0131.40 (1.06–1.85)
2n = 7042n = 1148
  G492 (69.9)853 (74.3)1, Reference
  A212 (30.1)295 (25.7)0.0391.25 (1.01–1.54)
rs1343151 IL23Rn = 348 (%)n = 574 (%)
  GG144 (41.4)236 (41.1)1, Reference
  GA159 (45.7)260 (45.3)0.991.00 (0.75–1.35)
  AA45 (12.9)78 (13.6)0.790.95 (0.61–1.47)
2n = 6962n = 1148
  G447 (64.2)732 (63.8)1, Reference
  A249 (35.8)416 (36.2)0.840.98 (0.80–1.20)
IL12RB-IL23R2n = 5322n = 916
  G-G280 (52.6)502 (54.8)1, Reference
  A-G122 (22.9)235 (25.7)0.590.93 (0.71–1.22)
  G-A81 (15.2)114 (12.4)0.141.27 (0.91–1.78)
  A-A49 (9.2)65 (7.1)0.141.35 (0.89–2.05)
  D′0.21
  r20.033